Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2025-12-29 @ 7:51 PM
Study NCT ID:
NCT07108504
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-08-07
First Post:
2025-07-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-08-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08-10
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-30
First Submit QC Date:
None
Study First Post Date:
2025-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-06
Last Update Post Date:
2025-08-07
Last Update Post Date Type:
ACTUAL